BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9794230)

  • 1. Identification of candidate target genes for EVI-1, a zinc finger oncoprotein, using a novel selection strategy.
    Kim JH; Hui P; Yue D; Aycock J; Leclerc C; Bjoring AR; Perkins AS
    Oncogene; 1998 Sep; 17(12):1527-38. PubMed ID: 9794230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Evi-1 zinc finger myeloid transforming protein binds to genomic fragments containing (GATA)n sequences.
    Matsugi T; Kreider BL; Delwel R; Cleveland JL; Askew DS; Ihle JN
    Oncogene; 1995 Jul; 11(1):191-8. PubMed ID: 7624127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EVI-1 zinc finger protein works as a transcriptional activator via binding to a consensus sequence of GACAAGATAAGATAAN1-28 CTCATCTTC.
    Morishita K; Suzukawa K; Taki T; Ihle JN; Yokota J
    Oncogene; 1995 May; 10(10):1961-7. PubMed ID: 7761097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence.
    Kurokawa M; Ogawa S; Tanaka T; Mitani K; Yazaki Y; Witte ON; Hirai H
    Oncogene; 1995 Sep; 11(5):833-40. PubMed ID: 7675444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG.
    Funabiki T; Kreider BL; Ihle JN
    Oncogene; 1994 Jun; 9(6):1575-81. PubMed ID: 8183551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common DNA-binding site for SZF1 and the BRCA1-associated zinc finger protein, ZBRK1.
    Peng H; Zheng L; Lee WH; Rux JJ; Rauscher FJ
    Cancer Res; 2002 Jul; 62(13):3773-81. PubMed ID: 12097288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the isoforms of MOVO zinc finger protein, a mouse homologue of Drosophila Ovo, as transcription factors.
    Unezaki S; Nishizawa M; Okuda-Ashitaka E; Masu Y; Mukai M; Kobayashi S; Sawamoto K; Okano H; Ito S
    Gene; 2004 Jul; 336(1):47-58. PubMed ID: 15225875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
    Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R
    Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leukemogenesis by the AML1/EVI-1 chimeric protein].
    Mitani K; Hirai H
    Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):33-9. PubMed ID: 10643333
    [No Abstract]   [Full Text] [Related]  

  • 11. Transcriptional repression by the proto-oncogene BCL-6.
    Seyfert VL; Allman D; He Y; Staudt LM
    Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation.
    Bartholomew C; Kilbey A; Clark AM; Walker M
    Oncogene; 1997 Feb; 14(5):569-77. PubMed ID: 9053855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of leukemogenesis by AML1/EVI-1.
    Mitani K
    Oncogene; 2004 May; 23(24):4263-9. PubMed ID: 15156182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts.
    Morishita K; Parganas E; Douglass EC; Ihle JN
    Oncogene; 1990 Jul; 5(7):963-71. PubMed ID: 2115646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP.
    Nitta E; Izutsu K; Yamaguchi Y; Imai Y; Ogawa S; Chiba S; Kurokawa M; Hirai H
    Oncogene; 2005 Sep; 24(40):6165-73. PubMed ID: 15897867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction of a SV40 promoter specific artificial transcription factor].
    Zhao XH; Zhu XD; Liu J; Rao XJ; Huang PT
    Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):608-12. PubMed ID: 15969093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome.
    Ogawa S; Kurokawa M; Tanaka T; Mitani K; Inazawa J; Hangaishi A; Tanaka K; Matsuo Y; Minowada J; Tsubota T; Yazaki Y; Hirai H
    Oncogene; 1996 Jul; 13(1):183-91. PubMed ID: 8700545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Saccharomyces cerevisiae in the identification of novel transcription factor DNA binding specificities.
    Henry KW; Carey B; Howard WR; Hoefner D; Noonan DJ
    Yeast; 2001 Mar; 18(5):445-54. PubMed ID: 11255252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of two alternatively spliced evi-1 proto-oncogene transcripts by cAMP in kidney cells.
    Bartholomew C; Clark AM
    Oncogene; 1994 Mar; 9(3):939-42. PubMed ID: 8108138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.